Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioTekna is an Italian healthcare technology and medical device company focused on non-invasive systems for health, prevention, and human performance. The company develops and commercializes biomedical devices used to assess body composition, autonomic nervous system function, chronic stress, chronic inflammation, pain, and related physiological parameters. Its portfolio includes products such as BIA-ACC, PPG Stress Flow, TomEEx, RegMatEx, HEG, and the OSO-Test diagnostic approach, supported by an internal data infrastructure called BioTekna Plus. BioTekna positions itself as a research, development, and training organization, combining device development with clinical validation, scientific collaborations, and professional education through its Open Academy of Medicine. The business appears to be centered on commercially available medical technologies rather than a drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioTekna.